Treatment of unresectable extrahepatic cholangiocarcinoma using hematoporphyrin photodynamic therapy: A prospective study
- 1 December 2016
- journal article
- research article
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 16, 110-118
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Photodynamic therapy for cholangiocarcinoma using low dose mTHPC (Foscan®)Photodiagnosis and Photodynamic Therapy, 2013
- Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinomaHPB, 2012
- Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancerAlimentary Pharmacology & Therapeutics, 2011
- Photodynamic therapy enhancement of anti-tumor immunityPhotochemical & Photobiological Sciences, 2011
- R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancerLiver International, 2010
- Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinomaHPB, 2009
- Enhancement of anti-tumor immunity by photodynamic therapyImmunologic Research, 2009
- Self‐expandable metal stents and trans‐stent light delivery: Are metal stents and photodynamic therapy compatible?Lasers in Surgery and Medicine, 2008
- Surgical and Palliative Management and Outcome in 184 Patients With Hilar CholangiocarcinomaAnnals of Surgery, 2006
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006